What is the Medical Cannabidiol Board?
The 2017 Medical Cannabidiol Act directs the Iowa Department of Public Health (IDPH) to establish a nine-member Medical Cannabidiol Board, consisting of eight practitioners representing neurology, pain management, gastroenterology, oncology, psychiatry, pediatrics, family medicine, and pharmacy, and one representative from law enforcement. The practitioners must be licensed in Iowa, nationally board-certified in their area of specialty, and knowledgeable about the use of medical cannabidiol. The law enforcement representative must be a regularly employed member of a police force of a city or county, including a sheriff, or of the state patrol, who is responsible for the prevention and detection of crime and the enforcement of Iowa criminal laws.
The Medical Cannabidiol Board shall convene at least twice a year but no more than four times a year, to:
- Accept and review petitions to add medical conditions, medical treatments, or debilitating diseases to the list of debilitating medical conditions for which the medical use of cannabidiol would be medically beneficial;
- Make recommendations to remove or add debilitating medical conditions to the list of allowable debilitating medical conditions for which the medical use of cannabidiol would be medically beneficial;
- Work with IDPH regarding the requirements for licensure of medical cannabidiol manufacturers and dispensaries, including licensing procedures;
- Advise IDPH regarding the location of medical cannabidiol manufacturers and dispensaries throughout the state; and
- Make recommendations related to the form and quantity of allowable medical uses of cannabidiol.
Recommendations made by the Medical Cannabidiol Board pursuant to
b. and e. above shall be considered by the Iowa Board of Medicine and, if approved, shall be adopted by the Iowa Board of Medicine by rule.
The Medical Cannabidiol Board must submit a report detailing the activities of the board by January 1 of each year. It may also make recommendations on statutory revisions to the definition of medical cannabidiol that increases the tetrahydrocannabinol (THC) level to more than three percent; however, Iowa’s General Assembly has the sole authority to review and amend the definition of medical cannabidiol for purposes of this Act.
A list of members of the newly appointed Medical Cannabidiol Board can be found here: Membership List. One board member vacancy representing gastroenterology remains. Application for the Medical Cannabidiol Board will be done through the Governor’s Office boards and commissions application website at https://openup.iowa.gov/openboard. The Governor will appoint members from the applicant pool.